搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
11 天
野村上调格兰德制药股票评级至中性,下调目标价
周一,野村/Instinet调整了对Gland Pharma Ltd (GLAND:IN)的立场,将股票评级从减持上调至中性。该公司同时略微调整了目标价,从之前的1,800.00印度卢比下调至1,790.00印度卢比。野村分析师指出,多个因素可能影响这家制药公司的未来表现,包括预期美国出口将有所改善。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Black boxes recovered
New tariffs coming Saturday
Opens probe into NPR, PBS
Todd exits NBC News
'As Tears Go By' singer dies
Partners w/ US national labs
Top leaders asked to resign
Weekly jobless claims fall
S3 release date revealed
Cause of death revealed
Inmate's transfer blocked
Hamas confirms death
Cancerous tumor removed
Seeking a new trial
Navajo men, partner indicted
DOJ sues to block deal
Ground stop amid IT outage
Apologizes for old tweets
Nashville bids for franchise
Recuses self from Act 10 suit
Confirmed interior secretary
US inflation ticked higher
IL won’t hire Jan. 6 rioters
To raise hourly pay
Receives $250K settlement
To again run for Senate?
Searching for joyriders
Shiffrin finishes 10th
Tour boat captain sentenced
Activists call for boycott
2 more victims in indictment
FDA approves painkiller
Michigan priest loses license
反馈